Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia-Reference-Cited by-同舟云学术

Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia

Published:2001-03 Issue:5 Volume:87 Page:547-553
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Hopkins Paul N,Stephenson Susan,Wu Lily L,Riley Ward A,Xin Yuanpei,Hunt Steven C

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events;J Chron Dis,1978

2. Identification and relative weight of cardiovascular risk factors;Hopkins;Cardiol Clin,1986

3. Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypercholesterolemia;Seed;N Engl J Med,1990

4. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics;Williams;Am J Cardiol,1993

5. WHO Familial Hypercholesterolemia Consultation Group. Familial Hypercholesterolemia. Report of a WHO Consultation. Paris: World Health Organization, 1998.

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Japanese Case of Familial Hypercholesterolemia with a Protein-truncating Variant in LDLR and a PCSK9 Variant without Significant Atherosclerosis but Showing Remarkable Achilles Tendon Thickening;Internal Medicine;2024-08-01

2. Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis;European Heart Journal;2024-07-08

3. Factors associated with the presence of tendon xanthomas in familial hypercholesterolemia;Revista Española de Cardiología (English Edition);2024-06

4. Factores asociados a la presencia de xantomas tendinosos en la hipercolesterolemia familiar;Revista Española de Cardiología;2024-06

5. Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy;Cureus;2023-05-01